| Date Filed | Type | Description |
| 06/09/2023 |
4
| GALA RENEE D (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.26, valued at
$44.1k
|
|
| 05/19/2023 |
4
| GALA RENEE D (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 6,000 shares
@ $131.7457, valued at
$790.5k
|
|
| 05/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/07/2023 |
4
| GALA RENEE D (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 12,784 shares
@ $0
Paid exercise price by delivering 1,557 shares
@ $142.78, valued at
$222.3k
|
|
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2022 |
4
| GALA RENEE D (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 1,633 shares
@ $162.88, valued at
$266k
|
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2020 |
4
| GALA RENEE D (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 16,600 shares
@ $0
Granted 3,652 options to buy
@ $109.45, valued at
$399.7k
Granted 37,848 options to buy
@ $109.45, valued at
$4.1M
|
|
| 03/18/2020 |
3
| GALA RENEE D (EVP & CFO) has filed a Form 3 on Jazz Pharmaceuticals plc |
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/21/2018 |
4
| GALA RENEE D (SVP, CFO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 6,697 shares
@ $24.79, valued at
$166k
|
|
| 08/22/2018 |
4
| GALA RENEE D (SVP, CFO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 6,695 shares
@ $26.95, valued at
$180.4k
|
|
| 08/22/2018 |
4
| GALA RENEE D (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 25,000 options to buy
@ $14.08, valued at
$352k
|
|
| 08/16/2018 |
4
| GALA RENEE D (SVP, CFO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 2,204 shares
@ $27.7386, valued at
$61.1k
Sold 39,839 shares
@ $26.7083, valued at
$1.1M
Sold 1,700 shares
@ $27.4254, valued at
$46.6k
|
|
| 05/22/2018 |
4
| GALA RENEE D (SVP, CFO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 10,000 shares
@ $24.2877, valued at
$242.9k
Paid exercise price by delivering 21,230 shares
@ $24.31, valued at
$516.1k
|
|
| 05/16/2018 |
4
| GALA RENEE D (SVP, CFO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 33,750 shares
@ $0 |
|
| 03/07/2018 |
4
| GALA RENEE D (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Bought 1,000 shares
@ $15.3, valued at
$15.3k
Bought 9,000 shares
@ $15.5335, valued at
$139.8k
|
|
| 02/22/2018 |
4
| GALA RENEE D (SVP, CFO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 5,387 shares
@ $29.09, valued at
$156.7k
|
|
| 02/14/2018 |
4
| GALA RENEE D (SVP, CFO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 9,000 shares
@ $0 |
|
| 11/22/2017 |
4
| GALA RENEE D (SVP, CFO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 6,753 shares
@ $28.58, valued at
$193k
|
|
| 08/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/23/2016 |
4
| GALA RENEE D (SVP, CFO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 4,306 shares
@ $27.89, valued at
$120.1k
|
|
| 06/28/2016 |
4
| GALA RENEE D (Director) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 70,000 options to buy
@ $5.11, valued at
$357.7k
|
|
|